Antiresorptive activity of denosumab in the treatment of osteoporosis in patients with rheumatoid arthritis

Antiresorptive activity of denosumab in the treatment of osteoporosis in patients with rheumatoid arthritis

Background: fracture risks assessment and determination of bone mineral density are modern methods, generally accepted and widely used. However, they have limitations and disadvantages for the dynamic evaluation of bone remodeling processes in RA-patients with low BMD. The investigation of bone reso...

Full description

Bibliographic Details
Main Authors:	Nadezhda Y. Banshchikova, Yelena A. Letyagina, Vitaliy O. Omelchenko, Maksim A. Korolev
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2018-12-01
Series:	Остеопороз и остеопатии
Subjects:	rheumatoid arthritis osteoporosis denosumab bisphosphonates β-ctx osteocalcin
Online Access:	https://osteo-endojournals.ru/osteo/article/viewFile/9826/7498

Similar Items

Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
by: Tetsuya Kaneko, et al.
Published: (2019-10-01)

Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
by: Takako Suzuki, et al.
Published: (2017-06-01)

Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis
by: Yukio Nakamura, et al.
Published: (2017-04-01)

Experience with denosumab therapy for osteoporosis in rheumatoid arthritis patients receiving glucocorticoids
by: I. S. Dydykina, et al.
Published: (2018-06-01)

EFFECT OF DENOSUMAB ON CLINICAL AND RADIOLOGICAL CHANGES IN RHEUMATOID ARTHRITIS: PRELIMINARY RESULTS
by: P. S. Dydykina, et al.
Published: (2015-04-01)

Comparative evaluation of denosumab efficacy of in patients with rheumatoid arthritis and postmenopausal osteoporosis: results of 1-year study in clinical practice
by: O. V. Dobrovolskaya, et al.
Published: (2019-05-01)

Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis
by: Suzuki T, et al.
Published: (2018-12-01)

CHANGES OF CLINICAL AND RADIOGRAPHIC PARAMETERS DURING DENOSUMAB THERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING GLUCOCORTICOIDS: PRELIMINARY RESULTS
by: P. S. Dydykina, et al.
Published: (2015-09-01)

Long-term treatment options for postmenopausal osteoporosis: results of recent clinical studies of Denosumab
by: Zhanna E. Belaya, et al.
Published: (2018-04-01)

Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
by: Suzuki T, et al.
Published: (2018-03-01)

Four-Year Teriparatide Followed by Denosumab vs. Continuous Denosumab in Glucocorticoid-Induced Osteoporosis Patients With Prior Bisphosphonate Treatment
by: Yasuaki Hirooka, et al.
Published: (2021-09-01)

The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
by: Yilin Zhu, et al.
Published: (2020-05-01)

The Bisphosphonates versus Denosumab Efficiency in Postmenopausal Osteoporosis Treatment
by: Lorena Ciumărnean, et al.
Published: (2017-05-01)

THE PROBLEM OF OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Irina Mikhailovna Marusenko, et al.
Published: (2009-12-01)

THE PROBLEM OF OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Irina Mikhailovna Marusenko, et al.
Published: (2009-12-01)

OSTEOPOROSIS IN A MALE PATIENT WITH RHEUMATOID ARTHRITIS (A CLINICAL CASE)
by: A. A. Muradyants, et al.
Published: (2014-11-01)

OSTEOPOROSIS IN A MALE PATIENT WITH RHEUMATOID ARTHRITIS (A CLINICAL CASE)
by: A. A. Muradyants, et al.
Published: (2014-11-01)

Results of an investigation of the biochemical markers of bone metabolism in males with rheumatoid arthritis
by: Marina Vasilyevna Letaeva
Published: (2013-12-01)

Results of an investigation of the biochemical markers of bone metabolism in males with rheumatoid arthritis
by: Marina Vasilyevna Letaeva
Published: (2013-12-01)

Current treatment of osteoporosis
by: Subramanian Nallasivan
Published: (2019-01-01)

Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment
by: Yasuaki Hirooka, et al.
Published: (2020-12-01)

Bone strength and management of postmenopausal fracture risk with antiresorptive therapies: considerations for women’s health practice
by: Cheung AM, et al.
Published: (2016-09-01)

Analysis of the subsequent treatment of osteoporosis by transitioning from bisphosphonates to denosumab, using quantitative computed tomography: A prospective cohort study
by: Koki Tsuchiya, et al.
Published: (2021-06-01)

Evaluation of Preventive Treatment Protocols for Patients under Antiresorptive Therapy Undergoing Tooth Extraction at a Swiss University Clinic
by: Ellen Pick, et al.
Published: (2021-09-01)

Analysis of utilization of bisphosphonates, strontium ranelate and denosumabe in Serbia, Finland, Norway and Denmark in the period 2013-2016
by: Cvjetković Đurđa M., et al.
Published: (2019-01-01)

Bone turnover markers relations to postmenopausal osteoporosis
by: Mečevska-Jovčevska Jasmina, et al.
Published: (2009-01-01)

Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
by: Jiaqi Wu, et al.
Published: (2018-08-01)

Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
by: Yong-Ki Min
Published: (2015-03-01)

Osteoporosis in men: epidemiology and treatment with denosumab
by: Sidlauskas KM, et al.
Published: (2014-04-01)

Evaluation of serum undercarboxylated osteocalcin in premenopausal rheumatoid arthritis patients: its correlation with disease activity and bone mineral density
by: Heba A Esaily, et al.
Published: (2016-01-01)

Potential protective effect of zoledronic acid when switching from long-term therapy of osteoporosis with denosumab
by: O. V. Yakushevskaya
Published: (2021-01-01)

Denosumab for the treatment of HIV-associated osteoporosis with fractures in a premenopausal woman
by: E. Marasco, et al.
Published: (2021-04-01)

Denosumab is the first gene engineered agent for the treatment of osteoporosis
by: O A Nikitinskaya, et al.
Published: (2012-09-01)

Evaluation of satisfaction and preference in patients with osteoporosis receiving Denosumab
by: Betül Sargın
Published: (2021-01-01)

Treatment of primary osteoporosis in men
by: Giusti A, et al.
Published: (2014-12-01)

Denosumab for the treatment of osteoporosis
by: Michael R. McClung
Published: (2017-03-01)

Denosumab Related Osteonecrosis of Jaw: a Case Report
by: Marco Vinícius de Sales Lima, et al.
Published: (2018-12-01)

Failure of Oral Risedronate Therapy to Prevent Spontaneous Vertebral Fracture in a Patient Ceasing Denosumab: A Cautionary Case
by: Dahlia F Davidoff, et al.
Published: (2020-10-01)

Gingival cell growth with antiresorptive treatment combined with corticosteroids or antiestrogen
by: Heidi M. Ekholm, et al.
Published: (2021-08-01)

OSTEOPOROSIS AND JOINT REPLACEMENT
by: Holzer Gerold, et al.
Published: (2018-08-01)